22nd week of 2016 patent applcation highlights part 7 |
Patent application number | Title | Published |
20160151320 | USE OF DHA, EPA OR DHA-DERIVED EPA FOR TREATING A PATHOLOGY ASSOCIATED WITH CELLULAR OXIDATIVE DAMAGE | 2016-06-02 |
20160151321 | METHODS FOR THE TREATMENT OF SIALORRHEA | 2016-06-02 |
20160151322 | METALLO-B-LACTAMASE INHIBITORS | 2016-06-02 |
20160151323 | METHODS FOR TREATING LEUKOPENIA AND THROMBOCYTOPENIA | 2016-06-02 |
20160151324 | IMPROVEMENTS IN OR RELATING TO ALLIUM EXTRACTS | 2016-06-02 |
20160151325 | NOVEL FORMULATIONS OF PHARMACOLOGICAL AGENTS, METHODS FOR THE PREPARATION THEREOF AND METHODS FOR THE USE THEREOF | 2016-06-02 |
20160151326 | Dronedarone for use in Leishmaniasis, Formulations and Associations for Use in Leishmaniasis | 2016-06-02 |
20160151327 | Methods of Reducing Blood Lactate Concentration | 2016-06-02 |
20160151328 | Terpene-Based Compositions, Processes Methodologies | 2016-06-02 |
20160151329 | METHOD OF PRODUCING PROANTHOCYANIDIN OLIGOMER | 2016-06-02 |
20160151330 | HEPATOCYTE-PROLIFERATING AGENT | 2016-06-02 |
20160151331 | METHODS OF USING (+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOI- SOINDOLINE-1,3-DIONE | 2016-06-02 |
20160151332 | 4-Methylpyrazole Formulations | 2016-06-02 |
20160151333 | METHODS AND COMPOSITIONS TO PREVENT OR TREAT BACTERIAL INFECTIONS | 2016-06-02 |
20160151334 | SUBSTANCE HAVING TYROSINE KINASE INHIBITORY ACTIVITY AND PREPARATION METHOD AND USE THEREOF | 2016-06-02 |
20160151335 | METHODS OF MODULATING CFTR ACTIVITY | 2016-06-02 |
20160151336 | COMPOUNDS AND METHODS FOR REGULATING INTEGRINS | 2016-06-02 |
20160151337 | ANNELATED PYRROLES AND THEIR USE AS CRAC INHIBITORS | 2016-06-02 |
20160151338 | NUTRACEUTICAL COMPOSITION FOR THE TREATMENT OF EXCESS WEIGHT AND MODERATE HYPERCHOLESTEROLEMIA/DYSGLYCEMIA | 2016-06-02 |
20160151339 | Treatment for Chemotherapy-Induced Peripheral Neuropathy | 2016-06-02 |
20160151340 | BOWEL CLEANSING COMPOSITION | 2016-06-02 |
20160151341 | TREATMENT OF ENERGY UTILIZATION DISEASE | 2016-06-02 |
20160151342 | COMPOUNDS AND METHODS TO TREAT ORGANOPHOSPHORUS POISONING | 2016-06-02 |
20160151343 | NON-FLUSHING NIACIN ANALOGUES, AND METHODS OF USE THEREOF | 2016-06-02 |
20160151344 | COMPOUNDS FOR USE IN THE TREATMENT OF NEUROBLASTOMA, EWING'S SARCOMA OR RHABDOMYOSARCOMA | 2016-06-02 |
20160151345 | N-ETHYL-N-PHENYL-1,2-DIHYDRO-4,5-DI-HYDROXY-1-METHYL-2-OXO-3-QUINOLINECARB- OXAMIDE, PREPARATION AND USES THEREOF | 2016-06-02 |
20160151346 | N-ETHYL-N-PHENYL-1,2-DIHYDRO-4,5-DI-HYDROXY-1-METHYL-2-OXO-3-QUINOLINECARB- OXAMIDE, PREPARATION AND USES THEREOF | 2016-06-02 |
20160151347 | PHARMACEUTICAL COMPOUNDS | 2016-06-02 |
20160151348 | COMPOUNDS USEFUL FOR TREATING DISEASES CAUSED BY RETROVIRUSES | 2016-06-02 |
20160151349 | PHARMACEUTICAL COMPOSITIONS COMPRISING 7-(1H-IMIDAZOL-4-YLMETHYL)-5,6,7,8-TETRAHYDRO-QUINOLINE FOR TREATING SKIN DISEASES AND CONDITIONS | 2016-06-02 |
20160151350 | PHARMACEUTICAL COMPOSITIONS WHICH INHIBIT FKBP52-MEDIATED REGULATION OF ANDROGEN RECEPTOR FUNCTION AND METHODS OF USING SAME | 2016-06-02 |
20160151352 | BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF | 2016-06-02 |
20160151355 | Pharmaceutical Formulation Containing Gelling Agent | 2016-06-02 |
20160151356 | Pharmaceutical Formulation Containing Gelling Agent | 2016-06-02 |
20160151357 | Pharmaceutical Formulation Containing Gelling Agent | 2016-06-02 |
20160151358 | Pharmaceutical Formulation Containing Gelling Agent | 2016-06-02 |
20160151359 | Method of Treating Dyskinesia | 2016-06-02 |
20160151360 | Pharmaceutical Formulation Containing Gelling Agent | 2016-06-02 |
20160151361 | CONTROLLED RELEASE HYDROCODONE FORMULATIONS | 2016-06-02 |
20160151362 | TARGETING HUMAN THYMIDYLATE KINASE INDUCES DNA REPAIR TOXICITY IN MALIGNANT TUMOR CELLS | 2016-06-02 |
20160151363 | Cadherin-11 Inhibitors and Methods of Use Thereof | 2016-06-02 |
20160151364 | 4-IMIDAZOPYRIDAZIN-1-YL-BENZAMIDES AND 4-IMIDAZOTRIAZIN-1-YL-BENZAMIDES AS BTK INHIBITORS | 2016-06-02 |
20160151365 | TRIZOL-1-OL ANALOGS ANTI-RETROVIRAL LATENCY DRUGS | 2016-06-02 |
20160151366 | Compositions and Methods for Treating Autism Spectrum Disorders | 2016-06-02 |
20160151367 | METHODS OF USING PHTHALAZINONE KETONE DERIVATIVES | 2016-06-02 |
20160151368 | THERAPEUTIC FORMULATION AND METHODS OF TREATMENT | 2016-06-02 |
20160151369 | SUBSTITUTED 3-PHENYLPROPYLAMINE DERIVATIVES FOR THE TREATMENT OF OPHTHALMIC DISEASES AND DISORDERS | 2016-06-02 |
20160151370 | Substituted Benzylpyrazoles | 2016-06-02 |
20160151371 | COMPOSITION FOR REGULATING IMMUNOLOGICAL ACTIVITY IN INTESTINE AND USE THEREOF | 2016-06-02 |
20160151372 | PYRROLOPYRIMIDINE COMPOUNDS FOR THE TREATMENT OF CANCER | 2016-06-02 |
20160151373 | COMBINATION TREATMENT OF CANCER | 2016-06-02 |
20160151374 | METHOD OF USING VASOCONSTRICTIVE AGENTS DURING ENERGY-BASED TISSUE THERAPY | 2016-06-02 |
20160151375 | SULFIDE ALKYL COMPOUNDS FOR HBV TREATMENT | 2016-06-02 |
20160151376 | BISARYL (THIO)MORPHOLINE DERIVATIVES AS S1P MODULATORS | 2016-06-02 |
20160151377 | USE OF SIGMA RECEPTOR LIGANDS FOR THE PREVENTION AND TREATMENT OF PAIN ASSOCIATED TO INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME (IC/BPS) | 2016-06-02 |
20160151378 | SALT OF 3-[(3--2-OXO-2,3-DIHYDRO-1H-INDOL-5-YL)METHYL]-1,3-THIAZOLIDINE-2,- 4-DIONE, ITS PREPARATION, AND FORMULATIONS CONTAINING I | 2016-06-02 |
20160151379 | COMBINATION THERAPIES FOR MALARIA | 2016-06-02 |
20160151380 | THERAPIES FOR DISEASES CAUSED BY ARTHROPOD-BORNE PARASITES | 2016-06-02 |
20160151381 | SALTS OF LORCASERIN WITH OPTICALLY ACTIVE ACIDS | 2016-06-02 |
20160151382 | Cooperative Medication Combination Systems | 2016-06-02 |
20160151383 | METHODS FOR TREATMENT OF DISEASES | 2016-06-02 |
20160151384 | NEW MODUS OF ADMINISTRATION OF IRON, AND NEW FORMULATIONS ADAPATED FOR THE SAID GOAL | 2016-06-02 |
20160151385 | STABLE FORMULATIONS FOR PARENTERAL INJECTION OF SMALL MOLECULE DRUGS | 2016-06-02 |
20160151386 | SUSTAINED RELEASE FORMULATIONS FOR THE TREATMENT OF INTRAOCULAR PRESSURE OR GLAUCOMA | 2016-06-02 |
20160151387 | COMPOSITIONS HAVING C-17 AND C-3 MODIFIED TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY | 2016-06-02 |
20160151388 | Methods and Compositions Related to Glucocorticoid Receptor Antagonism and Prostate Cancer | 2016-06-02 |
20160151389 | USE OF ERGOSTATRIEN-3 -OL | 2016-06-02 |
20160151390 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML) | 2016-06-02 |
20160151391 | NITRATED LIPIDS AND METHODS OF MAKING AND USING THEREOF | 2016-06-02 |
20160151392 | SELF-NANOEMULSION OF POORLY SOLUBLE DRUGS | 2016-06-02 |
20160151393 | PULMONARY PHARMACEUTICAL FORMULATIONS | 2016-06-02 |
20160151394 | Methods and Compositions for Treating Cancer | 2016-06-02 |
20160151395 | Tabletting Process | 2016-06-02 |
20160151396 | PHARMACEUTICAL COMPOSITION OF DOXYCYCLINE WITH REDUCED FOOD EFFECT | 2016-06-02 |
20160151397 | DOXYCYCLINE COMPOSITION | 2016-06-02 |
20160151398 | Compositions Comprising Zoledronic Acid or Related Compounds for Treatment of Complex Regional Pain Syndrome | 2016-06-02 |
20160151399 | BORON-CONTAINING SMALL MOLECULES | 2016-06-02 |
20160151400 | HYBRID SCFA-HYDROXYL-DERIVATIZED MONOSACCHARIDES, METHODS OF SYNTHESIS, AND METHODS OF TREATING DISORDERS | 2016-06-02 |
20160151401 | GLYCOLIPIDS AS TREATMENT FOR DISEASE | 2016-06-02 |
20160151402 | METHOD OF TREATING PULMONARY DISORDERS WITH LIPOSOMAL AMIKACIN FORMULATIONS | 2016-06-02 |
20160151403 | SMALL MOLECULE MODULATORS OF P53 FAMILY SIGNALING | 2016-06-02 |
20160151404 | Nucleic Acid Particles, Methods and Use Thereof | 2016-06-02 |
20160151405 | Pappalysin Regulator | 2016-06-02 |
20160151406 | COMBINATION CANCER THERAPY WITH C-MET INHIBITORS AND SYNTHETIC OLIGONUCLEOTIDES | 2016-06-02 |
20160151407 | Compositions and Methods for Treating Alzheimer's Disease and Other Tauopathies | 2016-06-02 |
20160151408 | NOVEL THERAPY FOR MULTIPLE SCLEROSIS USING VITAMIN D AND GUT BACTERIA | 2016-06-02 |
20160151409 | SYNERGISTIC ENHANCEMENT OF THE DELIVERY OF NUCLEIC ACIDS VIA BLENDED FORMULATIONS | 2016-06-02 |
20160151410 | CLEARANCE OF BIOACTIVE LIPIDS FROM MEMBRANE STRUCTURES BY CYCLODEXTRINS | 2016-06-02 |
20160151411 | APPARATUS FOR PREPARING GAS FOR TRANSDERMAL ABSORPTION, METHOD FOR PREPARING GAS FOR TRANSDERMAL ABSORPTION, AND GAS FOR TRANSDERMAL ABSORPTION | 2016-06-02 |
20160151412 | COMBINATION OF XENON WITH AN NMDA RECEPTOR ANTAGONIST FOR FIGHTING A NEURODEGENERATIVE DISEASE | 2016-06-02 |
20160151413 | SODIUM NITRITE-CONTAINING PHARMACEUTICAL COMPOSITIONS | 2016-06-02 |
20160151414 | Pure nano clacium powder and method | 2016-06-02 |
20160151415 | PHARMACEUTICAL COMPOSITION FOR IMPROVING HEALTH, CURE ABNORMALITIES AND DEGENERATIVE DISEASE, ACHIEVE ANTI-AGING EFFECT OF THERAPY AND THERAPEUTIC EFFECT ON MAMMALS AND METHOD THEREOF | 2016-06-02 |
20160151416 | INSULIN-MIMETICS AS THERAPEUTIC ADJUNCTS FOR BONE REGENERATION | 2016-06-02 |
20160151417 | COMPOSITION, METHOD AND KIT FOR FORMATION OF GALVANIC CELLS ON THE SKIN | 2016-06-02 |
20160151418 | CNS disease, disorder or condition treatment achieved through administering a neural precursor cell population containing cells having an exogenous Notch intracellular domain nucleic acid sequences | 2016-06-02 |
20160151419 | PERIPHERAL BLOOD STEM CELLS WITH IMPROVED ANGIOGENIC PROPERTIES AND USE THEREOF | 2016-06-02 |
20160151420 | COMPOSITION FOR PREVENTING AND TREATING LIVER FIBROSIS OR LIVER CIRRHOSIS, CONTAINING, AS ACTIVE INGREDIENT, MESENCHYMAL STEM CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS | 2016-06-02 |
20160151421 | METHODS AND COMPOSITIONS FOR LONG TERM HEMATOPOIETIC REPOPULATION | 2016-06-02 |
20160151422 | ISOLATION AND PURIFICATION OF HEMATOPOIETIC STEM CELLS FROM POST-LIPOSUCTION LIPOASPIRATES | 2016-06-02 |